QIMA Life Sciences (previously Bioalternatives and Synelvia) is a Contract Research Organization (CRO) established in 1996 and specializing in cellular and molecular pharmacology.

We offer assays ranging from in silico screening to non-invasive clinical sample bioanalysis, as well as in vitro and ex vivo assays.

QIMA Life Sciences contributes to the development of in vitro methods as an alternative to animal experimentation, by offering solutions dedicated to preclinical research and to the development of drug candidates and to cosmetic active ingredients and formulations.

Beyond this activity of product evaluation and development and thanks to our offer of customized competitive services based on collaborative innovation, QIMA Life Sciences can assist the health industry with its new strategic choices.

Our assays are performed on our two French sites, in Gençay (Vienne) and Labège (Haute-Garonne).

With 60 experts and two 1000 square meter laboratories, our firm helps the marketing and R&D departments of big European and American cosmetic and pharmaceutical groups to innovate in the field of project conceptualization and to substantiate and support their product claims.

KEY FIGURES

1000

square meter laboratory

60

employees
(30 scientists)

500 +

in vitro and ex vivo assays in our catalog

15 % +

R&D investments

300 +

studies / year

OUR LOCATION

EUROPE & WORLDWIDE

QIMA Life Sciences – Headquarters

1bis rue des plantes – CS 50011
86160 Gençay – FRANCE

+33 (0)5 49 36 11 37 – info-ls@qima.com

Find out more about the QIMA Group

QIMA is a leading service provider of laboratory testing solutions, inspection and certification, which works with international brand names, distributors and manufacturers to improve their product quality and compliance.
With 4,000 employees in 85 countries, QIMA is a partner of 14,000 customers in the fields of consumer goods and in the food industry.

>> More information